Review proposal, March 2008

Review proposal of NICE guidance no. 75 and 106; Peginterferon alfa and ribavirin for the treatment of mild and moderate hepatitis C
Proposal to proceed with review

The Institute has carried out a search for information relevant to this appraisal. We have identified a number of license extensions both planned and received since the original two guidance were issued. It therefore seems appropriate for a review to take place including these license extensions.

In order to be completely confident that this is appropriate, we are asking consultees and commentators with an interest in this topic, to inform us of any evidence which would suggest that an earlier review would be beneficial. 

Please note all comments received will be published on the Institute's website when a decision has been taken.

Please click here for a full list of the organisations we have contacted.

12 March 2008

This page was last updated: 02 January 2011